News Archive

Have a new product release you want to publish on Point of Care.net? Click here

Radiometer’s ABL90 analyzer 510(k) cleared More >

Roche Receives FDA Clearance for CoaguChek XS Pro More >

MAS to Integrate ITC’s AVOXimeter 4000 and AVOXimeter 1000E to RALS^®-Plus Click here
Quest Diagnostics HemoCue Subsidiary to Add U.S. Hospital Laboratory Connectivity to Its HemoCue 201 DM Point-of-Care Click here
Radiometer Announces Limited Launch of ABL^® Series Blood Gas Analyzer Module to RALS®-Plus Click here
Blood Glucose Benchmarking Results in U.S. Hospitals for 2008 Announced Click here
Wireless Monitoring of Blood Glucose More >
HemoCue granted FDA waiver for point-of-care test HemoCue, a wholly owned subsidiary of Quest Diagnostics, has announced that its HemoCue Albumin 201 System is the first quantitative point-of-care test for screening, diagnosing and monitoring microalbuminuria to be granted a CLIA waiver by the FDA.
For glucoses, tight theory a tough practice More >

Last updated: 10/18/2010 Questions or corrections: My Point of Care.net.© 2008 Medical Automation Systems, Inc. Legal Notice.
This web site is made possible in total by the support of Medical Automation Systems.

Roche Receives FDA Clearance for CoaguChek XS Pro More >

HemoCue granted FDA waiver for point-of-care test HemoCue, a wholly owned subsidiary of Quest Diagnostics, has announced that its HemoCue Albumin 201 System is the first quantitative point-of-care test for screening, diagnosing and monitoring microalbuminuria to be granted a CLIA waiver by the FDA.